Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tip W Loo

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Molecular Pharmacology|April 21, 2006
Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperonesYing Wang, M Claire Bartlett, Tip W Loo, et al.
Biochemical Pharmacology|December 6, 2011
Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pumpTip W Loo, M Claire Bartlett, Li Shi, et al.
The Journal of Biological Chemistry|October 4, 2007
Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the proteinYing Wang, Tip W Loo, M Claire Bartlett, et al.
Molecular Pharmacology|November 30, 2006
Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperonesYing Wang, Tip W Loo, M Claire Bartlett, et al.
The Journal of Biological Chemistry|July 24, 2004
The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulatorEva Y Chen, M Claire Bartlett, Tip W Loo, et al.
The Journal of Biological Chemistry|June 16, 2012
The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely togetherTip W Loo, M Claire Bartlett, Michael R Detty, et al.
Bioorganic & Medicinal Chemistry|June 26, 2012
Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1)Alexandra Orchard, Gregory A Schamerhorn, Brandon D Calitree, et al.
Plos One|October 13, 2011
Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoproteinZsolt Bikadi, Istvan Hazai, David Malik, et al.
Journal of Medicinal Chemistry|April 27, 2012
Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1)Sean P Ebert, Bryan Wetzel, Robert L Myette, et al.
Journal of Medicinal Chemistry|May 1, 2009
Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activityMichael K Gannon, Jason J Holt, Stephanie M Bennett, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Molecular Pharmacology|April 21, 2006
Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperonesYing Wang, M Claire Bartlett, Tip W Loo, et al.
Biochemical Pharmacology|December 6, 2011
Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pumpTip W Loo, M Claire Bartlett, Li Shi, et al.
The Journal of Biological Chemistry|October 4, 2007
Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the proteinYing Wang, Tip W Loo, M Claire Bartlett, et al.
Molecular Pharmacology|November 30, 2006
Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperonesYing Wang, Tip W Loo, M Claire Bartlett, et al.
The Journal of Biological Chemistry|July 24, 2004
The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulatorEva Y Chen, M Claire Bartlett, Tip W Loo, et al.
The Journal of Biological Chemistry|June 16, 2012
The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely togetherTip W Loo, M Claire Bartlett, Michael R Detty, et al.
Bioorganic & Medicinal Chemistry|June 26, 2012
Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1)Alexandra Orchard, Gregory A Schamerhorn, Brandon D Calitree, et al.
Plos One|October 13, 2011
Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoproteinZsolt Bikadi, Istvan Hazai, David Malik, et al.
Journal of Medicinal Chemistry|April 27, 2012
Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1)Sean P Ebert, Bryan Wetzel, Robert L Myette, et al.
Journal of Medicinal Chemistry|May 1, 2009
Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activityMichael K Gannon, Jason J Holt, Stephanie M Bennett, et al.
Pageof 7